![Frontiers | Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy via Inhibition of TGF-β/Smad Pathway | Pharmacology Frontiers | Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy via Inhibition of TGF-β/Smad Pathway | Pharmacology](https://www.frontiersin.org/files/Articles/850542/fphar-13-850542-HTML-r1/image_m/fphar-13-850542-g001.jpg)
Frontiers | Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy via Inhibition of TGF-β/Smad Pathway | Pharmacology
![Gliclazide teva italia 30 mg compresse a rilascio modificato - 30 mg compresse rilascio modificato 60 compresse in blister pvc/al Gliclazide teva italia 30 mg compresse a rilascio modificato - 30 mg compresse rilascio modificato 60 compresse in blister pvc/al](https://www.docpeter.it/media/catalog/product/r/o/ropinirolo_teva_italia_2_mg_compresse_rilascio_prolungato_28_compresse_in_bl_040814030.jpg)
Gliclazide teva italia 30 mg compresse a rilascio modificato - 30 mg compresse rilascio modificato 60 compresse in blister pvc/al
![Frontiers | Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy via Inhibition of TGF-β/Smad Pathway | Pharmacology Frontiers | Combination Therapy of Alpha-Lipoic Acid, Gliclazide and Ramipril Protects Against Development of Diabetic Cardiomyopathy via Inhibition of TGF-β/Smad Pathway | Pharmacology](https://www.frontiersin.org/files/Articles/850542/fphar-13-850542-HTML-r1/image_m/fphar-13-850542-g003.jpg)